187 related articles for article (PubMed ID: 35682840)
1. LXRα Regulates oxLDL-Induced Trained Immunity in Macrophages.
Findeisen HM; Voges VC; Braun LC; Sonnenberg J; Schwarz D; Körner H; Reinecke H; Sohrabi Y
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682840
[TBL] [Abstract][Full Text] [Related]
2. LXR Activation Induces a Proinflammatory Trained Innate Immunity-Phenotype in Human Monocytes.
Sohrabi Y; Sonntag GVH; Braun LC; Lagache SMM; Liebmann M; Klotz L; Godfrey R; Kahles F; Waltenberger J; Findeisen HM
Front Immunol; 2020; 11():353. PubMed ID: 32210962
[TBL] [Abstract][Full Text] [Related]
3. mTOR-Dependent Oxidative Stress Regulates oxLDL-Induced Trained Innate Immunity in Human Monocytes.
Sohrabi Y; Lagache SMM; Schnack L; Godfrey R; Kahles F; Bruemmer D; Waltenberger J; Findeisen HM
Front Immunol; 2018; 9():3155. PubMed ID: 30723479
[No Abstract] [Full Text] [Related]
4. Mechanisms of Trained Innate Immunity in oxLDL Primed Human Coronary Smooth Muscle Cells.
Schnack L; Sohrabi Y; Lagache SMM; Kahles F; Bruemmer D; Waltenberger J; Findeisen HM
Front Immunol; 2019; 10():13. PubMed ID: 30728822
[No Abstract] [Full Text] [Related]
5. Knock-down of the oxysterol receptor LXRα impairs cholesterol efflux in human primary macrophages: lack of compensation by LXRβ activation.
Ishibashi M; Filomenko R; Rébé C; Chevriaux A; Varin A; Derangère V; Bessède G; Gambert P; Lagrost L; Masson D
Biochem Pharmacol; 2013 Jul; 86(1):122-9. PubMed ID: 23313547
[TBL] [Abstract][Full Text] [Related]
6. OxLDL-mediated immunologic memory in endothelial cells.
Sohrabi Y; Lagache SMM; Voges VC; Semo D; Sonntag G; Hanemann I; Kahles F; Waltenberger J; Findeisen HM
J Mol Cell Cardiol; 2020 Sep; 146():121-132. PubMed ID: 32726647
[TBL] [Abstract][Full Text] [Related]
7. Activation of TRPV1 prevents OxLDL-induced lipid accumulation and TNF-α-induced inflammation in macrophages: role of liver X receptor α.
Zhao JF; Ching LC; Kou YR; Lin SJ; Wei J; Shyue SK; Lee TS
Mediators Inflamm; 2013; 2013():925171. PubMed ID: 23878415
[TBL] [Abstract][Full Text] [Related]
8. miR-206 controls LXRα expression and promotes LXR-mediated cholesterol efflux in macrophages.
Vinod M; Chennamsetty I; Colin S; Belloy L; De Paoli F; Schaider H; Graier WF; Frank S; Kratky D; Staels B; Chinetti-Gbaguidi G; Kostner GM
Biochim Biophys Acta; 2014 Jun; 1841(6):827-35. PubMed ID: 24603323
[TBL] [Abstract][Full Text] [Related]
9. Modified low density lipoprotein stimulates complement C3 expression and secretion via liver X receptor and Toll-like receptor 4 activation in human macrophages.
Mogilenko DA; Kudriavtsev IV; Trulioff AS; Shavva VS; Dizhe EB; Missyul BV; Zhakhov AV; Ischenko AM; Perevozchikov AP; Orlov SV
J Biol Chem; 2012 Feb; 287(8):5954-68. PubMed ID: 22194611
[TBL] [Abstract][Full Text] [Related]
10. Oxidized LDL Downregulates ABCA1 Expression via MEK/ERK/LXR Pathway in INS-1 Cells.
Lyu J; Fukunaga K; Imachi H; Sato S; Kobayashi T; Saheki T; Ibata T; Yoshimura T; Iwama H; Murao K
Nutrients; 2021 Aug; 13(9):. PubMed ID: 34578896
[TBL] [Abstract][Full Text] [Related]
11. Cholesterol efflux is LXRα isoform-dependent in human macrophages.
Ma AZ; Song ZY; Zhang Q
BMC Cardiovasc Disord; 2014 Jul; 14():80. PubMed ID: 24996838
[TBL] [Abstract][Full Text] [Related]
12. Oxidized LDL downregulates ATP-binding cassette transporter-1 in human vascular endothelial cells via inhibiting liver X receptor (LXR).
Zhu Y; Liao H; Xie X; Yuan Y; Lee TS; Wang N; Wang X; Shyy JY; Stemerman MB
Cardiovasc Res; 2005 Dec; 68(3):425-32. PubMed ID: 16099444
[TBL] [Abstract][Full Text] [Related]
13. Liver X receptor: a potential target in the treatment of atherosclerosis.
Savla SR; Prabhavalkar KS; Bhatt LK
Expert Opin Ther Targets; 2022 Jul; 26(7):645-658. PubMed ID: 36003057
[TBL] [Abstract][Full Text] [Related]
14. LXRalpha regulates human CETP expression in vitro and in transgenic mice.
Honzumi S; Shima A; Hiroshima A; Koieyama T; Ubukata N; Terasaka N
Atherosclerosis; 2010 Sep; 212(1):139-45. PubMed ID: 20494359
[TBL] [Abstract][Full Text] [Related]
15. Liver X receptor (LXR)-beta regulation in LXRalpha-deficient mice: implications for therapeutic targeting.
Quinet EM; Savio DA; Halpern AR; Chen L; Schuster GU; Gustafsson JA; Basso MD; Nambi P
Mol Pharmacol; 2006 Oct; 70(4):1340-9. PubMed ID: 16825483
[TBL] [Abstract][Full Text] [Related]
16. Emodin enhances cholesterol efflux by activating peroxisome proliferator-activated receptor-γ in oxidized low density lipoprotein-loaded THP1 macrophages.
Fu X; Xu AG; Yao MY; Guo L; Zhao LS
Clin Exp Pharmacol Physiol; 2014 Sep; 41(9):679-84. PubMed ID: 24837536
[TBL] [Abstract][Full Text] [Related]
17. Liver X receptor agonist inhibits proliferation of ovarian carcinoma cells stimulated by oxidized low density lipoprotein.
Scoles DR; Xu X; Wang H; Tran H; Taylor-Harding B; Li A; Karlan BY
Gynecol Oncol; 2010 Jan; 116(1):109-16. PubMed ID: 19854496
[TBL] [Abstract][Full Text] [Related]
18. Activation of liver X receptors prevents statin-induced death of 3T3-L1 preadipocytes.
Madsen L; Petersen RK; Steffensen KR; Pedersen LM; Hallenborg P; Ma T; Frøyland L; Døskeland SO; Gustafsson JA; Kristiansen K
J Biol Chem; 2008 Aug; 283(33):22723-36. PubMed ID: 18487205
[TBL] [Abstract][Full Text] [Related]
19. Non-redundant roles for LXRalpha and LXRbeta in atherosclerosis susceptibility in low density lipoprotein receptor knockout mice.
Bischoff ED; Daige CL; Petrowski M; Dedman H; Pattison J; Juliano J; Li AC; Schulman IG
J Lipid Res; 2010 May; 51(5):900-6. PubMed ID: 20388921
[TBL] [Abstract][Full Text] [Related]
20. Differential Role of Liver X Receptor (LXR)
Hansmann E; Mennillo E; Yoda E; Verreault M; Barbier O; Chen S; Tukey RH
Drug Metab Dispos; 2020 Apr; 48(4):255-263. PubMed ID: 31980500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
